Analysts recommendations
Roche: In a research note published by Richard Vosser, JP Morgan advises its customers to buy the stock. The target price is unchanged and still at CHF 400.
Novartis: In a research note, Goldman Sachs analyst Keyur Parekh has maintained his recommendation on the stock with a Buy rating. The target price remains unchanged at CHF 109.
Fresenius: Jefferies is negative on the stock with a Sell rating. The target price is still set at EUR 35.
Safran: Analyst Andrew Gollan from Berenberg research considers the stock attractive and recommends it with a Buy rating. The target price is lowered from EUR 140 to EUR 130.
Inditex: Initially Neutral on the company, RBC’s analyst Richard Chamberlain maintained his recommendation. The target price is decreased from EUR 29 to EUR 28.
Nike: Analyst Alexandra Walvis from Goldman Sachs research considers the stock attractive and recommends it with a Buy rating. The target price is increased from USD 154 to USD 164.
Fedex: Already positive, the research from Berenberg and its analyst William Fitzalan Howard still consider the stock as a Buy opportunity. The target price is set at 325 versus 320 USD.
Intel: In his latest research note, analyst Stacy Rasgon confirms his negative recommendation. The broker Bernstein is keeping its Sell rating. The target price is unchanged at USD 40.
Adidas: Warburg Research analyst Jörg Frey maintains his Sell rating on ADIDAS. The target price is unchanged and still at EUR 215.
Walmart: RBC’s analyst has raised his rating from Neutral to Buy. The target price is being increased from USD 153 to USD 170.
Wacker Chemie: In a research note, Warburg Research analyst Oliver Schwarz has maintained his recommendation on the stock with a Buy rating. The target price is increased from EUR 129 to EUR 135.
